Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Shares Outstanding (Diluted Average): 2014-2024

Historic Shares Outstanding (Diluted Average) for Altimmune (ALT) over the last 8 years, with Dec 2024 value amounting to $71.0 million.

  • Altimmune's Shares Outstanding (Diluted Average) rose 25.79% to $89.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.4 million, marking a year-over-year increase of 25.79%. This contributed to the annual value of $71.0 million for FY2024, which is 33.35% up from last year.
  • Altimmune's Shares Outstanding (Diluted Average) amounted to $71.0 million in FY2024, which was up 33.35% from $53.2 million recorded in FY2023.
  • Over the past 5 years, Altimmune's Shares Outstanding (Diluted Average) peaked at $71.0 million during FY2024, and registered a low of $25.6 million during FY2020.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $57.1 million, with a median of $53.2 million in 2023.
  • Data for Altimmune's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 61.03% (in 2021) over the last 5 years.
  • Altimmune's Shares Outstanding (Diluted Average) (Yearly) stood at $25.6 million in 2020, then spiked by 61.03% to $41.3 million in 2021, then grew by 13.67% to $46.9 million in 2022, then increased by 13.47% to $53.2 million in 2023, then skyrocketed by 33.35% to $71.0 million in 2024.